Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Programs

CAS reaches 150 millionth substance

Carbonitrile derivative is a promising compound for the treatment of cancer and immunological diseases

by Linda Wang
May 16, 2019

Article:

This article has been sent to the following recipient: